PL EN
REVIEW PAPER
Immunopathology and pulmonary complications associated with SARS-CoV-2 virus infection. Can plants help us?
 
More details
Hide details
1
TS Klinika Przychodnia Diagnostyki i Terapii Chorób Serca, Płuc i Naczyń, Centrum Leczenia Przeciwzakrzepowego, Polska
2
Zakład Profilaktyki Zagrożeń Środowiskowych Alergologii i Immunologii, Wydział Nauk o Zdrowiu, Warszawski Uniwersytet Medyczny, Polska
3
Katedra Medycyny, Wydział Nauk Medycznych i Nauk o Zdrowiu, Uniwersytet Technologiczno-Humanistyczny im. Kazimierza Pułaskiego w Radomiu, Polska
4
Zakład Biologii Molekularnej, Instytut Genetyki i Biotechnologii Zwierząt PAN, Polska
CORRESPONDING AUTHOR
Marta Stelmasiak   

Katedra Medycyny, Wydział Nauk Medycznych i Nauk o Zdrowiu, Uniwersytet Technologiczno-Humanistyczny im. Kazimierza Pułaskiego w Radomiu, Chrobrego 27, 26-600, Radom, Polska
Submission date: 2021-12-21
Final revision date: 2022-03-08
Acceptance date: 2022-03-28
Publication date: 2022-07-06
 
LW 2022;100(2):70–76
 
KEYWORDS
TOPICS
other
 
ABSTRACT
During the SARS-CoV-2 virus pandemic, which began in 2019, it has been observed that the vast majority of people have a mild clinical picture or asymptomatic COVID-19. However, approximately 10% of individuals infected with the virus will have a severe, potentially fatal clinical course associated with hyperinflammation, vascular endothelial damage, thrombotic complications and lung injury. To predict and make prognoses about course of COVID-19, it is necessary to understand the immunologic mechanisms induced after the infection. Knowledge of the infection immunopathology is essential for development of effective immunomodulatory therapy. The paper describes selected plant-derived immunomodulators that may exhibit preventive and soothing effects on COVID-19 disease symptoms.
eISSN:1509-5754
ISSN:0024-0745